Progress towards the UNAIDS 90-90-90 targets among persons aged 50 and older living with HIV in 13 African countries.
HIV epidemiology
HIV testing
PHIA
UNAIDS goals
ageing
older PLHIV
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
20
01
2022
accepted:
16
08
2022
entrez:
29
9
2022
pubmed:
30
9
2022
medline:
4
10
2022
Statut:
ppublish
Résumé
Achieving optimal HIV outcomes, as measured by global 90-90-90 targets, that is awareness of HIV-positive status, receipt of antiretroviral (ARV) therapy among aware and viral load (VL) suppression among those on ARVs, respectively, is critical. However, few data from sub-Saharan Africa (SSA) are available on older people (50+) living with HIV (OPLWH). We examined 90-90-90 progress by age, 15-49 (as a comparison) and 50+ years, with further analyses among 50+ (55-59, 60-64, 65+ vs. 50-54), in 13 countries (Cameroon, Cote d'Ivoire, Eswatini, Ethiopia, Kenya, Lesotho, Malawi, Namibia, Rwanda, Tanzania, Uganda, Zambia and Zimbabwe). Using data from nationally representative Population-based HIV Impact Assessments, conducted between 2015and 2019, participants from randomly selected households provided demographic and clinical information and whole blood specimens for HIV serology, VL and ARV testing. Survey weighted outcomes were estimated for 90-90-90 targets. Country-specific Poisson regression models examined 90-90-90 variation among OPLWH age strata. Analyses included 24,826 HIV-positive individuals (15-49 years: 20,170; 50+ years: 4656). The first, second and third 90 outcomes were achieved in 1, 10 and 5 countries, respectively, by those aged 15-49, while OPLWH achieved outcomes in 3, 13 and 12 countries, respectively. Among those aged 15-49, women were more likely to achieve 90-90-90 targets than men; however, among OPLWH, men were more likely to achieve first and third 90 targets than women, with second 90 achievement being equivalent. Country-specific 90-90-90 regression models among OPLWH demonstrated minimal variation by age stratum across 13 countries. Among OLPWH, no first 90 target differences were noted by age strata; three countries varied in the second 90 by older age strata but not in a consistent direction; one country showed higher achievement of the third 90 in an older age stratum. While OPLWH in these 13 countries were slightly more likely than younger people to be aware of their HIV-positive status (first 90), this target was not achieved in most countries. However, OPLWH achieved treatment (second 90) and VL suppression (third 90) targets in more countries than PLWH <50. Findings support expanded HIV testing, prevention and treatment services to meet ongoing OPLWH health needs in SSA.
Identifiants
pubmed: 36176030
doi: 10.1002/jia2.26005
pmc: PMC9522983
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e26005Subventions
Organisme : President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention
ID : #1U2GGH000994
Organisme : President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention
ID : 5NU2GGH001226
Informations de copyright
© 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
Références
J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):e33-5
pubmed: 27632148
PLoS One. 2013 Oct 15;8(10):e77101
pubmed: 24143205
Future Virol. 2011 Jun;6(6):755-767
pubmed: 22427781
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
BMC Public Health. 2020 Sep 9;20(1):1375
pubmed: 32907565
J Int AIDS Soc. 2020 Mar;23(3):e25470
pubmed: 32153117
J Aging Health. 2019 Apr;31(4):709-732
pubmed: 29318924
AIDS. 2012 Jul 31;26 Suppl 1:S85-91
pubmed: 22781181
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S97-S106
pubmed: 34166316
PLoS One. 2018 Mar 22;13(3):e0194732
pubmed: 29566062
MMWR Morb Mortal Wkly Rep. 2018 Jan 12;67(1):29-32
pubmed: 29329280
AIDS. 2014 Nov;28 Suppl 4:S453-9
pubmed: 25222641
AIDS. 2019 Feb 1;33(2):349-352
pubmed: 30557162
J Assoc Nurses AIDS Care. 2011 Jan-Feb;22(1):17-25
pubmed: 20471864
AIDS Behav. 2012 Jan;16(1):63-8
pubmed: 21739287
Ther Clin Risk Manag. 2020 Mar 04;16:169-180
pubmed: 32184609
Am J Epidemiol. 2003 May 15;157(10):940-3
pubmed: 12746247
Int J Equity Health. 2015 Mar 07;14:26
pubmed: 25889558
AIDS. 2018 Jul 31;32(12):1551-1561
pubmed: 29746295
PLoS One. 2018 Apr 23;13(4):e0196158
pubmed: 29684054
BMC Public Health. 2020 Jun 19;20(1):970
pubmed: 32560717
PLoS One. 2016 Nov 9;11(11):e0162967
pubmed: 27828979
AIDS. 2018 Jul 31;32(12):1563-1569
pubmed: 29762172
AIDS. 2012 Jul 31;26 Suppl 1:S1-5
pubmed: 22713477
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S17-S27
pubmed: 34166309
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):e9-e17
pubmed: 27926667
AIDS. 2019 Dec 15;33 Suppl 3:S213-S226
pubmed: 31490781
PLoS One. 2018 Nov 29;13(11):e0207005
pubmed: 30496302
J Int AIDS Soc. 2016 Feb 15;19(1):20673
pubmed: 26894388
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S6-S16
pubmed: 34166308
BMC Public Health. 2021 Apr 3;21(1):650
pubmed: 33812381
Sex Transm Infect. 2020 Jun;96(4):271-276
pubmed: 31243144
Int J STD AIDS. 2012 Jul;23(7):490-6
pubmed: 22844003
J Int AIDS Soc. 2019 Feb;22(2):e25239
pubmed: 30734510
BMC Geriatr. 2018 Oct 25;18(1):257
pubmed: 30359223
Clin Infect Dis. 2014 Dec 15;59(12):1787-97
pubmed: 25182245